Skip to content

G&A at other companies

Idexx Laboratories logo
Idexx LaboratoriesIDXX
$119.12M+30.1%
NeoGenomics logo
NeoGenomicsNEO
$65.74M-3.6%

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$2.07B+93.1%
Enterprise value$2.7B+45.5%
P/S2.4×+1.2×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Reported directly by Neogen in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: Neogen’s 10-Q, filed April 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neogen's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neogen's G&A?
Neogen (NEOG) reported G&A of $60.3M in Q4 2025.
How has Neogen's G&A changed year-over-year?
Neogen's G&A increased by 8.1% year-over-year, from $55.8M to $60.3M.
What is the long-term trend for Neogen's G&A?
Over 4 years (2021 to 2025), Neogen's G&A has grown at a 43.7% compound annual growth rate (CAGR), from $51.2M to $218.21M.
What does G&A mean?
Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.